What is Accolade?
Accolade operates at the intersection of health technology and patient advocacy, providing a comprehensive platform that leverages analytics to streamline healthcare plan selection and care delivery. By integrating clinical decision support with personalized navigation services, the company addresses the complexities of modern healthcare systems. Its market position is defined by a value-based care model that prioritizes individual health outcomes, effectively bridging the gap between insurance providers and the end-user experience through sophisticated digital infrastructure.
How much funding has Accolade raised?
Accolade has raised a total of $716.7M across 12 funding rounds:
Series C
$30M
Series D
$2.8M
Private Equity
$38.6M
Other Financing Round
$22.5M
Series E
$70M
Other Financing Round
$50M
Corporate Investment
$20M
Stock Offering
$220.5M
Stock Offering
$221.4M
Series C (2013): $30M, investors not publicly disclosed
Series D (2014): $2.8M backed by Carrick Capital Partners, Accretive, LLC, and Comcast Ventures
Private Equity (2015): $38.6M with participation from McKesson and Independence Blue Cross
Other Financing Round (2015): $22.5M led by Independence Health Group
Series E (2016): $70M supported by Madrona Venture Group and Andreesen Horowitz
Other Financing Round (2018): $50M featuring Total Access Fund, Madrona Venture Group, Cross Creek Advisors, Andreessen Horowitz, Strawberry Creek Ventures, Blue Ivy Ventures, SPIKE VENTURES, Castor Ventures, Chestnut Street Ventures, Fission Ventures, Triphammer Ventures, Carrick Capital Partners, and Alumni Ventures
Corporate Investment (2019): $20M backed by Humana
Stock Issuance/Offering (2020): $220.5M with participation from Undisclosed
Stock Issuance/Offering (2020): $221.4M led by Undisclosed
Key Investors in Accolade
Andreesen Horowitz
A prominent private American venture capital firm that provides strategic backing to both early-stage startups and established growth-stage enterprises.
Madrona Venture Group
A long-standing venture capital investment firm with a focus on consumer internet, commercial software, and high-growth technology services.
Comcast Ventures
The venture capital affiliate of Comcast Corporation, specializing in providing capital and strategic support to B2B and B2C technology companies.
What's next for Accolade?
With the support of its latest capital injection, Accolade is well-positioned to accelerate its growth strategy, focusing on the expansion of its advocacy services and the refinement of its proprietary analytics engine. The company is expected to deepen its integration with enterprise-level healthcare partners, further embedding its platform into the fabric of corporate health benefits. As the industry shifts toward more personalized, data-centric models, Accolade's strategic roadmap emphasizes the scaling of its care delivery capabilities to meet the rising demand for transparent and efficient health management solutions.
See full Accolade company page
